Mutual of America Capital Management LLC Sells 1,440 Shares of Xylem Inc. (NYSE:XYL)

Mutual of America Capital Management LLC reduced its stake in shares of Xylem Inc. (NYSE:XYL) by 4.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 32,282 shares of the industrial products company’s stock after selling 1,440 shares during the period. Mutual of America Capital Management LLC’s holdings in Xylem were worth $3,692,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Bruce G. Allen Investments LLC bought a new position in shares of Xylem during the 4th quarter valued at approximately $27,000. Coppell Advisory Solutions LLC bought a new position in shares of Xylem during the 2nd quarter valued at approximately $45,000. KB Financial Partners LLC bought a new position in shares of Xylem during the 1st quarter valued at approximately $42,000. NBC Securities Inc. bought a new position in shares of Xylem during the 3rd quarter valued at approximately $38,000. Finally, Orion Capital Management LLC bought a new position in shares of Xylem during the 3rd quarter valued at approximately $48,000. 87.96% of the stock is owned by institutional investors.

Xylem Stock Performance

NYSE XYL opened at $128.02 on Wednesday. Xylem Inc. has a 1 year low of $87.59 and a 1 year high of $130.86. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.76 and a quick ratio of 1.30. The stock has a market capitalization of $31.03 billion, a PE ratio of 47.07, a P/E/G ratio of 2.54 and a beta of 1.10. The company’s 50 day simple moving average is $126.79 and its two-hundred day simple moving average is $111.91.

Xylem (NYSE:XYL) last posted its earnings results on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.96 by $0.03. The business had revenue of $2.12 billion for the quarter, compared to analysts’ expectations of $2.05 billion. Xylem had a net margin of 8.27% and a return on equity of 9.65%. The business’s revenue for the quarter was up 40.6% compared to the same quarter last year. During the same period in the prior year, the company posted $0.92 EPS. Analysts predict that Xylem Inc. will post 4.13 earnings per share for the current fiscal year.

Xylem Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 20th. Stockholders of record on Wednesday, February 21st were given a dividend of $0.36 per share. The ex-dividend date of this dividend was Tuesday, February 20th. This represents a $1.44 annualized dividend and a dividend yield of 1.12%. This is a boost from Xylem’s previous quarterly dividend of $0.33. Xylem’s dividend payout ratio (DPR) is 52.94%.

Insider Activity

In other news, SVP Franz Cerwinka sold 2,408 shares of the firm’s stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the sale, the senior vice president now owns 11,750 shares in the company, valued at approximately $1,431,032.50. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other news, SVP Franz Cerwinka sold 2,408 shares of the firm’s stock in a transaction on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the sale, the senior vice president now owns 11,750 shares in the company, valued at approximately $1,431,032.50. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the firm’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total transaction of $122,890.00. Following the sale, the chief accounting officer now owns 2,935 shares in the company, valued at approximately $360,682.15. The disclosure for this sale can be found here. Corporate insiders own 0.27% of the company’s stock.

Analyst Ratings Changes

XYL has been the subject of several analyst reports. BNP Paribas initiated coverage on shares of Xylem in a report on Tuesday, March 12th. They issued an “outperform” rating and a $150.00 price objective for the company. Stifel Nicolaus raised their price objective on shares of Xylem from $136.00 to $150.00 and gave the stock a “buy” rating in a report on Wednesday, February 7th. Raymond James raised shares of Xylem from an “underperform” rating to a “market perform” rating in a report on Thursday, January 4th. Robert W. Baird raised their price objective on shares of Xylem from $141.00 to $148.00 and gave the stock an “outperform” rating in a report on Thursday, March 21st. Finally, Citigroup raised their price objective on shares of Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a report on Monday, April 8th. Four investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, Xylem has an average rating of “Moderate Buy” and an average price target of $135.44.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.